Materia Malta, the wholly-owned subsidiary of medical cannabis and wellness company Meteria, has received a European Union Good Manufacturing Practices (EU GMP) certification from the Malta Medicines Authority, the company has announced.

This certification, described as a “global gold standard for pharmaceutical production”, will enable Materia to begin processing and exporting medical cannabis flower from Malta into end markets across Europe, following the final post-certification steps.

Materia CEO Deepak Anand commented: “Becoming EU GMP certified in Malta represents our most significant milestone since we embarked on this project over two years ago. We are excited to turn the engine on and showcase the full potential of a Malta-based cannabis process to the industry, especially global partners seeking access to the European market”.

With the certification, the company will utilise its network of qualified supply chain partners to introduce “new, high-quality medical cannabis” to the European market, and notably Germany.

“The reality is Germany is larger as a market today than all other European markets”, said Nick Pateras, Managing Director for Europe. “For us, Germany is markets one, two and three”.

Additionally, Materia says it intends to apply for a license amendment to process cannabis extracts imminently, leveraging the comprehensive preparatory work already completed”.